AbbVie to acquire Cerevel Therapeutics for $8.7 Billion
AbbVie Inc. (ABBV: NYE) is said to be closing in on a significant deal to acquire Cerevel Therapeutics Holdings Inc. in a…
Browse research
AbbVie Inc. (ABBV: NYE) is said to be closing in on a significant deal to acquire Cerevel Therapeutics Holdings Inc. in a…
GitLab (GTLB: NSD) announced impressive earnings and performance results in its recently released Q3 report. Despite a challenging economic environment, the company…
Dell Technologies (DELL: NYE) experienced a decline in revenue during the third quarter. The multinational technology company, which is well-known for its…
US Stock Ratings Name Symbol Analyst Action Rating Target Price Arbor Realty Trust ABR Wedbush Securities Reiterates Outperform 17 AdTheorent Holding Company…
Cigna Corporation (CI: NYE) is considering selling its medicare advantage business. This strategic decision could have far-reaching implications for the company, particularly…